Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;69(12):e29925.
doi: 10.1002/pbc.29925. Epub 2022 Aug 21.

Low-dose proton radiotherapy for pediatric choroidal hemangioma: A case series

Jovany J Franco  1 , Kevin X Liu  2 , Myrsini Ioakeim-Ioannidou  2 , Jose R Davila  3 , Yen-Lin Chen  1   2 , Ivana K Kim  1   3 , Evangelos S Gragoudas  1   3 , Shizuo Mukai  1   3 , Shannon M MacDonald  1   2
Affiliations

Low-dose proton radiotherapy for pediatric choroidal hemangioma: A case series

Jovany J Franco et al. Pediatr Blood Cancer. 2022 Dec.

Abstract

Management of pediatric choroidal hemangioma complicated by large exudative retinal detachment can be challenging, with few options available. Limited data have been published on outcomes following proton radiotherapy (PRT) for management of these patients. In this retrospective case series, nine patients were treated with a low-dose PRT regimen of 20 Gy(relative biological effectiveness [RBE]) in 10 fractions, and two were treated with 15 Gy(RBE) in four fractions. Visual acuity improved in seven patients (64%) and remained stable in the remaining four (36%). In patients with imaging follow-up (10 patients), subretinal fluid resolved in nine patients (90%) and tumor thickness decreased or remained stable in 10 (100%). Complications were observed in eight of 11 patients (73%). One patient developed grade 2 cataract; otherwise, no grade ≥2 complications were observed.

Keywords: Sturge-Weber syndrome; choroidal hemangioma; diffuse choroidal hemangioma; pediatric oncology; proton radiotherapy; vascular anomaly.

PubMed Disclaimer

References

REFERENCES

    1. Witschel H, Font RL. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol. 1976;20(6):415-431. https://doi.org/10.1016/0039-6257(76)90067-9
    1. Yonekawa Y, MacDonald SM, Shildkrot Y, Mukai S. Standard fractionation low-dose proton radiotherapy for diffuse choroidal hemangiomas in pediatric Sturge-Weber syndrome. J AAPOS. 2013;17(3):318-322. https://doi.org/10.1016/j.jaapos.2013.01.003
    1. Tsipursky MS, Golchet PR, Jampol LM. Photodynamic therapy of choroidal hemangioma in Sturge-Weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol. 2011;56(1):68-85. https://doi.org/10.1016/j.survophthal.2010.08.002
    1. Schilling H, Sauerwein W, Lommatzsch A, et al. Long term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol. 1997;81(4):267-273. https://doi.org/10.1136/bjo.81.4.267
    1. Zografos L, Egger E, Bercher L, Chamot L, Munkel G. Proton beam irradiation of choroidal hemangiomas. Am J Ophthalmol. 1998;126(2):261-268. https://doi.org/10.1016/S0002-9394(98)00150-0

Publication types

LinkOut - more resources